Biliary Tract Diseases clinical trials

The registry lists 59 studies for Biliary Tract Diseases across more than 10 countries. 12 are recruiting or about to start. 30 of them are mainly about Biliary Tract Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02. Counting its 21 narrower conditions too, such as Biliary Tract Neoplasms: 2,339 studies, 589 open.

Get an email when these change. Save the Biliary Tract Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 28
Status unknown: 11
Not yet recruiting: 10
Withdrawn: 3
Recruiting: 2
Terminated: 2

Phase

Phase 2: 13
Phase 3: 5
Phase 4: 1
Phase 1: 1

Where

United States: 15
China: 9
Canada: 7
Italy: 7
France: 6
Poland: 6

Who runs them

Mirum Pharmaceuticals, Inc. (6) · RenJi Hospital (5) · Boston Scientific Corporation (2) · Lawrence Charles Hookey (2) · University of Florida (2) · HighTide Therapeutics (Hong Kong) Limited (2) · Amsterdam UMC, location VUmc (1) · Ajou University School of Medicine (1)

What is being tested here

Drugs under test in Biliary Tract Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Esketamine	1	0	1
Upadacitinib	1	0	1
Ciprofol	1	0	1
Maralixibat	0	2	5
Berberine ursodeoxycholate	0	0	2
Glutathione	0	1	1
Alfentanil	0	0	1
Remifentanil	0	0	1
Gemcitabine	0	0	1
Fluorouracil	0	0	1

Coming up

0phase 3 studies under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Dec 2026Nurse-Led Education Before ERCP: Effects on Patient Knowledge and Anxiety · Gazi University
Feb 2027Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer · RenJi Hospital
Jun 2027The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases · RenJi Hospital
Jul 2027Biochemical Response and Clinical Outcomes in Patients With PBC · RenJi Hospital
Nov 2027The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching · RenJi Hospital

Who these studies take

Of the 2 Biliary Tract Diseases studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 59 studies, recruiting or not: 25% stop at 75 or younger and 15% at 65; 19% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Cholecystectomy, Biliary Diseases, and Colorectal Adenoma Risk: A Real-World Retrospective StudyNov 2, 2026NCT07908576

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 → or search them.